{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/2051714792004287616.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NDL_BIB_ID","@value":"11565254"}},{"identifier":{"@type":"DOI","@value":"10.1007/s10157-013-0849-x"}},{"identifier":{"@type":"URI","@value":"http://id.ndl.go.jp/digimeta/11565254"}},{"identifier":{"@type":"URI","@value":"https://dl.ndl.go.jp/pid/11565254"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10157-013-0849-x.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s10157-013-0849-x/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10157-013-0849-x"}},{"identifier":{"@type":"PMID","@value":"23913115"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Proposal of remission criteria for IgA nephropathy"}],"dcterms:alternative":[{"@value":"Proposal of remission criteria for IgA nephropathy"}],"dc:language":"en","description":[{"notation":[{"@value":"収集根拠 : オンライン資料収集制度"},{"@value":"資料形態 : テキストデータ"},{"@value":"コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/2061714792004287617","@type":"Researcher","foaf:name":[{"@value":"Keiichi Matsuzaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751158647808","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10468572"},{"@type":"NRID","@value":"1000010468572"},{"@type":"NRID","@value":"9000005990282"},{"@type":"NRID","@value":"9000398624487"},{"@type":"NRID","@value":"9000415088579"},{"@type":"NRID","@value":"9000402763942"},{"@type":"NRID","@value":"9000309181770"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/hyy"}],"foaf:name":[{"@value":"Hitoshi Suzuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801189441152","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"70372935"},{"@type":"NRID","@value":"1000070372935"},{"@type":"NRID","@value":"9000019083452"},{"@type":"NRID","@value":"9000273016503"},{"@type":"NRID","@value":"9000256090958"},{"@type":"NRID","@value":"9000380978493"},{"@type":"NRID","@value":"9000000301149"},{"@type":"NRID","@value":"9000381455620"},{"@type":"NRID","@value":"9000020513812"},{"@type":"NRID","@value":"9000414346507"},{"@type":"NRID","@value":"9000361700398"},{"@type":"NRID","@value":"9000415088577"},{"@type":"NRID","@value":"9000343333470"},{"@type":"NRID","@value":"9000255722233"},{"@type":"NRID","@value":"9000378652447"},{"@type":"NRID","@value":"9000346931995"},{"@type":"NRID","@value":"9000356658855"},{"@type":"NRID","@value":"9000335558611"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/juntendo1227"}],"foaf:name":[{"@value":"Yusuke Suzuki"}]}],"publication":{"publicationIdentifier":[{"@type":"ISSN","@value":"14377799"},{"@type":"LISSN","@value":"14377799"},{"@type":"PISSN","@value":"13421751"},{"@type":"EISSN","@value":"14377799"}],"prism:publicationName":[{"@value":"Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology"}],"dc:publisher":[{"@value":"Springer Nature"}],"prism:publicationDate":"2013-08-04","prism:volume":"18(3)","prism:startingPage":"481","prism:endingPage":"486"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://id.ndl.go.jp/digimeta/11565254"},{"@id":"https://dl.ndl.go.jp/pid/11565254"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10157-013-0849-x.pdf"},{"@id":"http://link.springer.com/article/10.1007/s10157-013-0849-x/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10157-013-0849-x"}],"foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Data%20Collection","dc:title":"Data Collection"},{"@id":"https://cir.nii.ac.jp/all?q=Incidence","dc:title":"Incidence"},{"@id":"https://cir.nii.ac.jp/all?q=Patient%20Selection","dc:title":"Patient Selection"},{"@id":"https://cir.nii.ac.jp/all?q=Remission%20Induction","dc:title":"Remission Induction"},{"@id":"https://cir.nii.ac.jp/all?q=Glomerulonephritis,%20IGA","dc:title":"Glomerulonephritis, IGA"},{"@id":"https://cir.nii.ac.jp/all?q=Proteinuria","dc:title":"Proteinuria"},{"@id":"https://cir.nii.ac.jp/all?q=Treatment%20Outcome","dc:title":"Treatment Outcome"},{"@id":"https://cir.nii.ac.jp/all?q=Japan","dc:title":"Japan"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Hematuria","dc:title":"Hematuria"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782268175872","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25670408"},{"@type":"JGN","@value":"JP25670408"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25670408/"}],"notation":[{"@language":"ja","@value":"抗体結合型バイオナノカプセルを応用した炎症白血球特異的新規腎障害治療法の開発"},{"@language":"en","@value":"Development of novel therapy for kidney injury by leukocyte targeting antibody-fused Bionanocapsules"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782290697984","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26305029"},{"@type":"JGN","@value":"JP26305029"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26305029/"}],"notation":[{"@language":"ja","@value":"慢性腎臓病患者におけるテロメア消耗と環境因子の国際比較"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257190331264","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24591213"},{"@type":"JGN","@value":"JP24591213"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24591213/"}],"notation":[{"@language":"ja","@value":"糖鎖異常ＩｇＡ１免疫複合体および扁桃細胞のＩｇＡ腎症における病態解明"},{"@language":"en","@value":"Pathogenic role of galactose-deficient IgA1 contained immune complexes and tonsillar cells in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257222565376","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25293195"},{"@type":"JGN","@value":"JP25293195"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25293195/"}],"notation":[{"@language":"ja","@value":"ミッドカインによる内皮細胞由来の血管作動因子を介した血圧調整のメカニズムの解明"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257278728192","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26460449"},{"@type":"JGN","@value":"JP26460449"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26460449/"}],"notation":[{"@language":"ja","@value":"IgA腎症に対する扁桃摘出・ステロイドパルス療法の効果に関する分子・病理学的研究"},{"@language":"en","@value":"The study on the effect of tonsillectomy combined with steroid pulse therapy against IgA nephropathy"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218991744512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"TWEAK/Fn14 system and crescent formation in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390752320000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current treatment status of IgA nephropathy in Japan: a questionnaire survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1360023720970130304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692584897152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620429971584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620974548480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Slower Decline of Glomerular Filtration Rate in the Japanese General Population: A Longitudinal 10-Year Follow-Up Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905604371840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Analysis of the impact of obesity on the prognosis of IgA nephropathy according to renal function and sex"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095932598784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Natural History and Prognostic Factors of IgA Nephropathy Presented with Isolated Microscopic Hematuria in Chinese Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232174379264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232420202240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046163254016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Natural history and risk factors for immunoglobulin a nephropathy in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518681274624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Proteinuria and the risk of developing end-stage renal disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994560049664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN): A Double-Blind, Randomized, Placebo-Controlled Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420593057536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predictors for progression in immunoglobulin A nephropathy with significant proteinuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368701122688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Remission of Proteinuria Improves Prognosis in IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369905472512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Corticosteroid Effectiveness in IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319912924032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320561637888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268664745344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Corticosteroids in IgA nephropathy: a randomised controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288130849536","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Initial intravenous methylprednisolone pulse therapy in active IgA nephropathy for childhood"},{"@language":"ja","@value":"多剤併用療法前にステロイドパルス療法を施行した小児IgA 腎症の腎予後に関する検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390025794717906688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two-year Follow-up of IgA Nephropathy Patients Who Developed Gross Hematuria Following COVID-19 Vaccination: A Case Series and Literature Review"}]},{"@id":"https://cir.nii.ac.jp/crid/2050307417120421376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/2051433317029634560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of methods of steroid administration combined with tonsillectomy for IgA nephropathy patients"}]},{"@id":"https://cir.nii.ac.jp/crid/2051996266985713280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/2051996266988177920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Utility of remission criteria for the renal prognosis of IgA nephropathy"}]}],"dataSourceIdentifier":[{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R100000039-I11565254"},{"@type":"CROSSREF","@value":"10.1007/s10157-013-0849-x"},{"@type":"KAKEN","@value":"PRODUCT-15127904"},{"@type":"KAKEN","@value":"PRODUCT-15231887"},{"@type":"KAKEN","@value":"PRODUCT-14702110"},{"@type":"KAKEN","@value":"PRODUCT-15001451"},{"@type":"KAKEN","@value":"PRODUCT-15261000"},{"@type":"OPENAIRE","@value":"doi_dedup___::a2b30ccaff5923b7f9e17feb17bfb53d"},{"@type":"CROSSREF","@value":"10.1186/s12882-015-0022-8_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1007/s10157-016-1282-8_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1007/s13730-020-00508-3_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.3165/jjpn.oa.2018.0144_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1007/s10157-023-02396-0_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5548-25_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfv221_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1007/s10157-024-02519-1_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1007/s10157-021-02069-w_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0251294_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.3390/jcm11113173_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"},{"@type":"CROSSREF","@value":"10.34067/kid.0000000000000498_references_DOI_GJiHv8ykVg4BtLOD8fklVNqJ1fW"}]}